Dompé U.S. to Pay $32 Million Over Medicare Co-Pay Kickbacks
Dompé has agreed to pay $32 million to resolve allegations that it used patient assistance foundations to cover Medicare beneficiaries’ co-pays for Oxervate, its prescription drug, turning what appeared to be charitable assistance into what federal authorities alleged were unlawful inducements to purchase the company’s product.
